Body Mass Index and Morbidity in Patients Hospitalized With COVID-19
Is body mass index associated with morbidity in patients hospitalized with COVID-19?
Critical Care
Associations Found Between Plasma SARS-CoV-2 Viral RNA and COVID-19 Severity, Mortality
Researchers conducted a study to determine whether SARS-CoV-2 viral RNA detected in the bloodstreams of patients with COVID-19 is reflective of viremia or related to host immune responses and outcomes.
Intravenous Vitamin D Protects Organs, Reduces Short-Term Mortality From Sepsis
A meta-analysis of 10 RCTs showed the use of IV vitamin D for sepsis is promising, but further research is needed.
Clinical Efficacy, Safety of Janus Kinase Inhibitors in Patients Hospitalized With COVID-19
Investigators conducted a meta-analysis of 3 randomized controlled trials that compared the clinical safety and efficacy of janus kinase inhibitors with placebo or standard care for the treatment of patients with COVID-19.
Ethnic Disparities in Influenza-Associated Hospitalization and Death
Analysis of 10 years of data revealed that racial and ethnic minorities experienced more adverse outcomes from severe influenza.
Hydroxychloroquine, Remdesivir, and Dexamethasone Usage in Patients With COVID-19
Researchers examining COVID-19 data from a 13-month period found variations in US usage of dexamethasone, remdesivir, and hydroxychloroquine.
Outcomes of Hospital-Acquired Infections in Patients With Severe COVID-19
Investigators conducted a retrospective analysis to assess the characteristics and outcomes of patients hospitalized with severe COVID-19 who developed a hospital-acquired infection.
Outcomes for Milrinone vs Dobutamine in Cardiogenic Shock
Which inotropic agent should clinicians use in patients with cardiogenic shock, milirone or dobutamine?
Corticosteroids May Reduce Ventilation Use, Duration in Patients With ARDS
A review of 18 meta-analyses of corticosteroid use in ARDS examined corticosteroids’ effect on ARDS prevention, mortality, ventilator-free days, and ICU stay.
Do Bruton Tyrosine Kinase Inhibitors Improve Outcomes for SARS-CoV-2?
An NIH review explored whether Bruton tyrosine kinase inhibitors decreased oxygen requirements and hospitalizations for patients with SARS-CoV-2.
- Loading...
Loading...
Next post in Critical Care
Loading... 
Loading...